First female CEO for GlaxoSmithKline

First female CEO for GlaxoSmithKline

GlaxoSmithKline is getting its first female chief executive.

The pharmacuetical giant has named its consumer healthcare boss Emma Walmsley as chief executive to replace Andrew Witty when he retires next March.

Ms Walmsley has been appointed chief executive designate and will join a small band of women at the top of the UK's biggest listed companies when she takes on the post.

She has headed Glaxo's £6bn consumer healthcare arm since it was created in March 2015 as part of a joint venture deal with Novartis.

Ms Walmsley joined Glaxo in 2010 from L'Oreal, where she held a variety of marketing and general management roles in the UK, Europe and United States over a 17-year career at the group.

She said: "I am delighted and honoured to be appointed GSK's next chief executive.

"GSK is a company that leads both in science and in the way it does business.

"We have momentum in the group and as the demand for medical innovation and trusted healthcare products continues to rise, we have the opportunity and the potential to create meaningful benefits for patients, consumers and our shareholders."

Witty announced plans to retire on March 31 2017 earlier this year, ending nearly nine years at the helm and more than three decades with Britain's biggest drugs company.

Philip Hampton, chairman of Glaxo, said Ms Walmsley's appointment follows a "very thorough and rigorous" selection process.

He added: "Emma is an outstanding leader with highly valuable experience of building and running major global businesses and a strong track record of delivering growth and driving performance in healthcare."

Ms Walmsley has been a member of Glaxo's corporate executive team since 2011 and will join its board of directors from January.

Glaxo said Ms Walmsley's salary is yet to be announced, with Glaxo soon to begin talks with shareholders as part of an overhaul of executive pay.

Her base salary will be announced on January 1, while her total pay package will be set out in the group's annual report next spring.

It comes as executive pay is in the spotlight at the group after it was disclosed that Sir Andrew's total pay surged by 71% to £6.7m last year, despite falling core earnings and sales.

He was paid a salary of just under £1.1m for 2015, while he was also handed an annual bonus payment of £2.2m and long-term share awards worth £2.6m, although 25% of his annual bonus is deferred.

More in this Section

Berlin moves to freeze its runaway rents for five yearsBerlin moves to freeze its runaway rents for five years

Draghi in this week’s farewell can point to jobs growthDraghi in this week’s farewell can point to jobs growth

Six projects overseen by Science Foundation Ireland to share €25m to support new researchSix projects overseen by Science Foundation Ireland to share €25m to support new research

Limerick Council decision to issue enforcement notice against retail store challenged in the High CourtLimerick Council decision to issue enforcement notice against retail store challenged in the High Court


Lifestyle

Carol O’Callaghan continues her round-up of home interior shops in country towns and the outer reaches of our cities, finding more treasure troves which offer something new and a touch of exclusivityMade in Munster: The best interior shops in country towns

When the Irish Examiner broke the news that an ultra-inquisitive deer photobombed newlyweds at Killarney’s Ladies View the story went viral.Wedding of the Week: Time for Australian celebrations for bride and groom photobombed by deer

At the start of the 10th and final episode of Confronting: OJ Simpson, a series which has been downloaded over five million times since launching in June, host Kim Goldman is in tears, talking to her father about how strong he was through the murder of her brother, his son,Ron Goldman.Podcast Corner: Host relives brother’s death in famous case

Thomas McCarthy pays tribute to his late friend — poet and journalist Seán Dunne'Seán Dunne was one of the most loved people I ever knew'

More From The Irish Examiner